Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in treatment and prevention of recurrence of anogenital warts (HIPvac trial)

Macey L Murray, Jade Meadows, Caroline J. Dore, Andrew Copas, Lewis J. Haddow, Charles John Nash Lacey, M. Jit, Kate Soldan, Kate Bennett, Michelle Tetlow, Mayura Nathan, Richard Gilson

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Number of pages9
JournalBMC Medical Research Methodology
Issue number125
Publication statusPublished - 6 Nov 2018

Bibliographical note

© The Author(s). 2018.

Cite this